Naomi Hunder

Insider Reports History

Location
Seattle, WA
Signature
/s/ Jeffrey C. Pepe, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Naomi Hunder:

Company Role Class Num Shares Value Price $ Report Date Ownership
Silverback Therapeutics, Inc. Chief Medical Officer Common Stock 54,427 $205,897 $3.78 02 May 2022 Direct
Silverback Therapeutics, Inc. Chief Medical Officer Stock Option (right to buy) 86,355 02 May 2022 Direct

Insider Reports Filed by Naomi Hunder

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SPRY Silverback Therapeutics, Inc. 02 May 2022 2 $0 4 Chief Medical Officer 04 May 2022, 17:07
SPRY Silverback Therapeutics, Inc. 01 Feb 2022 3 $0 4 Chief Medical Officer 02 Feb 2022, 16:18